New York State Common Retirement Fund Prothena Corp Public LTD CO Transaction History

New York State Common Retirement Fund

$73.9 Billion
Q3 2024

A detailed history of New York State Common Retirement Fund transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, New York State Common Retirement Fund holds 14,279 shares of PRTA stock, worth $200,048. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,279

Previous 18,379 22.31%

Holding current value

$200,048

Previous $379,000 36.94%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$16.73 - $24.79 $68,593 - $101,639	-4,100 Reduced 22.31%	14,279 $239,000
Q2 2024 Jul 31, 2024	SELL	$19.54 - $26.15 $272,993 - $365,341	-13,971 Reduced 43.19%	18,379 $379,000
Q1 2024 May 07, 2024	SELL	$24.75 - $40.66 $32,125 - $52,776	-1,298 Reduced 3.86%	32,350 $801,000
Q4 2023 Feb 01, 2024	BUY	$32.31 - $52.32 $86,429 - $139,956	2,675 Added 8.64%	33,648 $1.22 Million
Q3 2023 Nov 07, 2023	SELL	$47.3 - $70.6 $9,554 - $14,261	-202 Reduced 0.65%	30,973 $1.49 Million
Q2 2023 Aug 07, 2023	SELL	$48.26 - $78.59 $19,304 - $31,436	-400 Reduced 1.27%	31,175 $2.13 Million
Q1 2023 May 02, 2023	SELL	$46.97 - $58.27 $197,508 - $245,025	-4,205 Reduced 11.75%	31,575 $1.53 Million
Q4 2022 Jan 30, 2023	SELL	$52.05 - $65.0 $31,802 - $39,715	-611 Reduced 1.68%	35,780 $2.16 Million
Q3 2022 Nov 08, 2022	BUY	$25.16 - $60.63 $41,916 - $101,009	1,666 Added 4.8%	36,391 $2.21 Million
Q2 2022 Aug 04, 2022	SELL	$22.73 - $39.98 $121,560 - $213,813	-5,348 Reduced 13.35%	34,725 $943,000
Q1 2022 May 05, 2022	BUY	$30.27 - $49.22 $281,268 - $457,352	9,292 Added 30.19%	40,073 $1.47 Million
Q4 2021 Feb 02, 2022	BUY	$42.11 - $73.26 $186,168 - $323,882	4,421 Added 16.77%	30,781 $1.52 Million
Q3 2021 Nov 02, 2021	SELL	$48.2 - $78.89 $180,750 - $295,837	-3,750 Reduced 12.45%	26,360 $1.88 Million
Q2 2021 Aug 02, 2021	BUY	$21.63 - $57.65 $50,635 - $134,958	2,341 Added 8.43%	30,110 $1.55 Million
Q2 2020 Aug 07, 2020	SELL	$9.56 - $12.51 $97,512 - $127,602	-10,200 Reduced 26.86%	27,769 $290,000
Q3 2019 Nov 07, 2019	SELL	$6.89 - $10.45 $27,084 - $41,078	-3,931 Reduced 9.38%	37,969 $298,000
Q2 2019 Aug 09, 2019	BUY	$8.85 - $12.49 $2,655 - $3,747	300 Added 0.72%	41,900 $443,000
Q2 2018 Aug 10, 2018	SELL	$10.99 - $44.21 $712,130 - $2.86 Million	-64,798 Reduced 60.9%	41,600 $607,000
Q4 2017 Feb 13, 2018	BUY	$35.44 - $63.76 $407,489 - $733,112	11,498 Added 12.12%	106,398 $3.99 Million
Q3 2017 Nov 06, 2017	BUY	$53.83 - $67.75 $2.87 Million - $3.61 Million	53,300 Added 128.13%	94,900 $6.15 Million
Q2 2017 Aug 11, 2017	BUY	N/A	41,600	41,600 $2.25 Million

Others Institutions Holding PRTA

# of Institutions

184

Shares Held

42.7M

Call Options Held

162K

Put Options Held

102K

View Full List

About PROTHENA CORP PUBLIC LTD CO

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $657M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

More about PRTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account

New York State Common Retirement Fund Prothena Corp Public LTD CO Transaction History